Skip to main content

Drug Safety

Ausgabe 8/2023

Inhalt (11 Artikel)

Editorial

Future of ChatGPT in Pharmacovigilance

Hanyin Wang, Yanyi Jenny Ding, Yuan Luo

Review Article

Nephrotoxicity of Amoxicillin and Third-Generation Cephalosporins: An Updated Review

Anne-Sophie Garnier, Guillaume Drablier, Marie Briet, Jean-François Augusto

Scoping Review

Use of Electronic Health Record Data for Drug Safety Signal Identification: A Scoping Review

Sharon E. Davis, Luke Zabotka, Rishi J. Desai, Shirley V. Wang, Judith C. Maro, Kevin Coughlin, José J. Hernández-Muñoz, Danijela Stojanovic, Nigam H. Shah, Joshua C. Smith

Open Access Original Research Article

Automatic Extraction of Comprehensive Drug Safety Information from Adverse Drug Event Narratives in the Korea Adverse Event Reporting System Using Natural Language Processing Techniques

Siun Kim, Taegwan Kang, Tae Kyu Chung, Yoona Choi, YeSol Hong, Kyomin Jung, Howard Lee

Open Access Original Research Article

Serially Combining Epidemiological Designs Does Not Improve Overall Signal Detection in Vaccine Safety Surveillance

Faaizah Arshad, Martijn J. Schuemie, Fan Bu, Evan P. Minty, Thamir M. Alshammari, Lana Y. H. Lai, Talita Duarte-Salles, Stephen Fortin, Fredrik Nyberg, Patrick B. Ryan, George Hripcsak, Daniel Prieto-Alhambra, Marc A. Suchard

Correction

Correction to: Comment on: “Should Antidepressants be Avoided in Pregnancy?”

Alain Braillon, Susan Bewley, Aubrey Blumsohn, Florian Naudet